These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7888679)
1. Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene. Zhou M; Yeager AM; Smith SD; Findley HW Blood; 1995 Mar; 85(6):1608-14. PubMed ID: 7888679 [TBL] [Abstract][Full Text] [Related]
2. Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias. Wojcik I; Szybka M; Golanska E; Rieske P; Blonski JZ; Robak T; Bartkowiak J Neoplasma; 2005; 52(4):318-24. PubMed ID: 16059649 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression. Zhou M; Gu L; Yeager AM; Findley HW Leukemia; 1998 Nov; 12(11):1756-63. PubMed ID: 9823951 [TBL] [Abstract][Full Text] [Related]
4. High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis. Marks DI; Kurz BW; Link MP; Ng E; Shuster JJ; Lauer SJ; Brodsky I; Haines DS Blood; 1996 Feb; 87(3):1155-61. PubMed ID: 8562942 [TBL] [Abstract][Full Text] [Related]
5. Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia. Zhou M; Gu L; Abshire TC; Homans A; Billett AL; Yeager AM; Findley HW Leukemia; 2000 Jan; 14(1):61-7. PubMed ID: 10637478 [TBL] [Abstract][Full Text] [Related]
6. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines. Taylor AC; Shu L; Danks MK; Poquette CA; Shetty S; Thayer MJ; Houghton PJ; Harris LC Med Pediatr Oncol; 2000 Aug; 35(2):96-103. PubMed ID: 10918230 [TBL] [Abstract][Full Text] [Related]
7. MDM2 antagonist nutlin-3 is a potent inducer of apoptosis in pediatric acute lymphoblastic leukemia cells with wild-type p53 and overexpression of MDM2. Gu L; Zhu N; Findley HW; Zhou M Leukemia; 2008 Apr; 22(4):730-9. PubMed ID: 18273046 [TBL] [Abstract][Full Text] [Related]
8. MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas. Maestro R; Gloghini A; Doglioni C; Gasparotto D; Vukosavljevic T; De Re V; Laurino L; Carbone A; Boiocchi M Blood; 1995 Jun; 85(11):3239-46. PubMed ID: 7756655 [TBL] [Abstract][Full Text] [Related]
9. Altered expression of p53 and MDM2 proteins in hematological malignancies. Koníková E; Kusenda J Neoplasma; 2003; 50(1):31-40. PubMed ID: 12687276 [TBL] [Abstract][Full Text] [Related]
10. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of MDM2 in acute childhood lymphoblastic leukemia. Gustafsson B; Stål O; Gustafsson B Pediatr Hematol Oncol; 1998; 15(6):519-26. PubMed ID: 9842645 [TBL] [Abstract][Full Text] [Related]
12. [Involvement of WT1 gene expression in regulation of P53 and MDM2 proteins function in acute lymphoblastic leukemia]. Bartkowiak J; Wójcik I; Stankiewicz W Pol Merkur Lekarski; 2001 Nov; 11(65):402-5. PubMed ID: 11852808 [TBL] [Abstract][Full Text] [Related]
13. Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Findley HW; Gu L; Yeager AM; Zhou M Blood; 1997 Apr; 89(8):2986-93. PubMed ID: 9108419 [TBL] [Abstract][Full Text] [Related]
14. MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia. Gu L; Findley HW; Zhou M Blood; 2002 May; 99(9):3367-75. PubMed ID: 11964305 [TBL] [Abstract][Full Text] [Related]
15. The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild-type p53 protein. Keleti J; Quezado MM; Abaza MM; Raffeld M; Tsokos M Am J Pathol; 1996 Jul; 149(1):143-51. PubMed ID: 8686737 [TBL] [Abstract][Full Text] [Related]
16. MDM2 protein overexpression inhibits apoptosis of TF-1 granulocyte-macrophage colony-stimulating factor-dependent acute myeloblastic leukemia cells. Urashima M; Teoh G; Chauhan D; Ogata A; Shirahama S; Kaihara C; Matsuzaki M; Matsushima H; Akiyama M; Yuza Y; Maekawa K; Anderson KC Blood; 1998 Aug; 92(3):959-67. PubMed ID: 9680365 [TBL] [Abstract][Full Text] [Related]
17. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127 [TBL] [Abstract][Full Text] [Related]
18. Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Zhang X; Gu L; Li J; Shah N; He J; Yang L; Hu Q; Zhou M Cancer Res; 2010 Dec; 70(23):9895-904. PubMed ID: 20935220 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of the MDM2 oncogene in leukemia and lymphoma. Watanabe T; Ichikawa A; Saito H; Hotta T Leuk Lymphoma; 1996 May; 21(5-6):391-7, color plates XVI following 5. PubMed ID: 9172803 [TBL] [Abstract][Full Text] [Related]
20. mdm2-P2 transcript levels predict the functional activity of the p53 tumor suppressor in primary leukemic cells. Bull EK; Chakrabarty S; Brodsky I; Haines DS Oncogene; 1998 Apr; 16(17):2249-57. PubMed ID: 9619834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]